A Prospective Clinical Study on Reduced-intensity Radiotherapy for Stage I/II Low-risk Nasal-type NK/T-cell Lymphoma Achieving Complete Remission After Chemotherapy

Clinical trial NCT07628738 · RECRUITING

Trial details

NCT number: NCT07628738
Sponsor: Ruijin Hospital
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Lymphoma (Non-Hodgkin's Lymphoma)

Start date: 2026-07-01
Primary completion: 2032-05-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.